Recent Quotes
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

38.20 +3.40 (+9.77%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,702,904
Open 35.76
Bid (Size) 37.70 (4,800)
Ask (Size) 38.00 (600)
Prev. Close 34.80
Today's Range 35.12 - 38.44
52wk Range 32.99 - 117.33
Shares Outstanding 115,926,629
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
News headline image
Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire

Performance

YTD
N/A
N/A
1 Month
-54.3%
-54.3%
3 Month
-56.7%
-56.7%
6 Month
-43.4%
-43.4%
1 Year
-23.6%
-23.6%

More News

Read More
News headline image
Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations
Via TheNewswire.com
Nasdaq, S&P 500 Futures Point To Strong New-Year Open On Wall Street: Why TSLA, BIDU, SLV, STLA Are On Traders' Radar Today ↗
Via Stocktwits
Topics Stocks
News headline image
Stocks making big moves yesterday: FuelCell Energy, Corcept, and PacBio
Via StockStory
Why Is CORT Stock Falling Today? ↗
Via Stocktwits
News headline image
Kaplan Fox Announces an Investigation Into Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations
Via TheNewswire.com
News headline image
Kaplan Fox Announces an Investigation Into Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations
Via NewMediaWire
News headline image
Why Xeris Biopharma Stock Zoomed 7% Higher on Wednesday ↗
Via The Motley Fool
News headline image
Why Corcept Therapeutics Plummeted by 50% Today ↗
Via The Motley Fool
News headline image
Why Corcept (CORT) Shares Are Falling Today
Via StockStory
Here are the top movers in Wednesday's session. ↗
Via Chartmill
News headline image
Kaplan Fox & Kilsheimer LLP is Investigating Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations
Via TheNewswire.com
News headline image
Kaplan Fox & Kilsheimer LLP is Investigating Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations
Via NewMediaWire
Top movers analysis in the middle of the day on 2025-12-31: top gainers and losers in today's session. ↗
Via Chartmill
The market is filled with gapping stocks in Wednesday's session. ↗
Via Chartmill
News headline image
Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism
From Corcept Therapeutics Incorporated
Via Business Wire
News headline image
3 Cash-Producing Stocks with Questionable Fundamentals
Via StockStory
News headline image
Why Corcept (CORT) Stock Is Trading Lower Today
Via StockStory
Topics Artificial Intelligence
News headline image
Corcept (CORT): Buy, Sell, or Hold Post Q3 Earnings?
Via StockStory
Topics Stocks
News headline image
Why Corcept (CORT) Stock Is Down Today
Via StockStory
Topics Artificial Intelligence Economy Supply Chain
News headline image
Corcept (CORT) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Corcept Therapeutics Inc (NASDAQ:CORT) Presents a Strong Growth and Technical Breakout Case ↗
Via Chartmill
News headline image
Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know
Via StockStory
Topics Economy
News headline image
CORCEPT THERAPEUTICS INC (NASDAQ:CORT): A Case Study in Affordable Growth Investing ↗
Via Chartmill

Frequently Asked Questions

Is Corcept Therapeutics Incorporated - Common Stock publicly traded?
Yes, Corcept Therapeutics Incorporated - Common Stock is publicly traded.
What exchange does Corcept Therapeutics Incorporated - Common Stock trade on?
Corcept Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Corcept Therapeutics Incorporated - Common Stock?
The ticker symbol for Corcept Therapeutics Incorporated - Common Stock is CORT on the Nasdaq Stock Market
What is the current price of Corcept Therapeutics Incorporated - Common Stock?
The current price of Corcept Therapeutics Incorporated - Common Stock is 38.20
When was Corcept Therapeutics Incorporated - Common Stock last traded?
The last trade of Corcept Therapeutics Incorporated - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of Corcept Therapeutics Incorporated - Common Stock?
The market capitalization of Corcept Therapeutics Incorporated - Common Stock is 4.43B
How many shares of Corcept Therapeutics Incorporated - Common Stock are outstanding?
Corcept Therapeutics Incorporated - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>